Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The valency of fatty acid conjugates impacts siRNA pharmacokinetics, distribution, and efficacy in vivo
Annabelle Biscans, Andrew H. Coles, Dimas Echeverria, et al.
Journal of Controlled Release (2019) Vol. 302, pp. 116-125
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Therapeutic siRNA: state of the art
Bo Hu, Liping Zhong, Yuhua Weng, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 1095
Nucleic acid delivery for therapeutic applications
Akash Gupta, Jason L. Andresen, Rajith S. Manan, et al.
Advanced Drug Delivery Reviews (2021) Vol. 178, pp. 113834-113834
Closed Access | Times Cited: 219
Fatty acid conjugation enhances potency of antisense oligonucleotides in muscle
Thazha P. Prakash, Adam E. Mullick, Richard Lee, et al.
Nucleic Acids Research (2019) Vol. 47, Iss. 12, pp. 6029-6044
Open Access | Times Cited: 116
Conjugation of hydrophobic moieties enhances potency of antisense oligonucleotides in the muscle of rodents and non-human primates
Michael E. Østergaard, Michaela Jackson, Audrey Low, et al.
Nucleic Acids Research (2019)
Open Access | Times Cited: 76
Overcoming the challenges of tissue delivery for oligonucleotide therapeutics
Tufan Gökirmak, Mehran Nikan, Svenja Wiechmann, et al.
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 7, pp. 588-604
Closed Access | Times Cited: 60
Rational design of a JAK1-selective siRNA inhibitor for the modulation of autoimmunity in the skin
Qi Tang, Hassan H. Fakih, Mohammad Zain UI Abideen, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 28
Lipid nanoparticles for RNA delivery: Self-assembling vs driven-assembling strategies
Valeria Nele, Virginia Campani, Seyedeh Alia Moosavian, et al.
Advanced Drug Delivery Reviews (2024) Vol. 208, pp. 115291-115291
Open Access | Times Cited: 13
Multispecies-targeting siRNAs for the modulation of JAK1 in the skin
Qi Tang, Katherine Y. Gross, Hassan H. Fakih, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 1, pp. 102117-102117
Open Access | Times Cited: 12
Structural optimization of siRNA conjugates for albumin binding achieves effective MCL1-directed cancer therapy
Ella N. Hoogenboezem, Shrusti S. Patel, Justin H. Lo, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
A critical analysis of methods used to investigate the cellular uptake and subcellular localization of RNA therapeutics
Kirsten Deprey, Nefeli Batistatou, Joshua A. Kritzer
Nucleic Acids Research (2020) Vol. 48, Iss. 14, pp. 7623-7639
Open Access | Times Cited: 55
The chemical structure and phosphorothioate content of hydrophobically modified siRNAs impact extrahepatic distribution and efficacy
Annabelle Biscans, Jillian Caiazzi, Sarah M. Davis, et al.
Nucleic Acids Research (2020) Vol. 48, Iss. 14, pp. 7665-7680
Open Access | Times Cited: 52
Docosanoic acid conjugation to siRNA enables functional and safe delivery to skeletal and cardiac muscles
Annabelle Biscans, Jillian Caiazzi, Nicholas McHugh, et al.
Molecular Therapy (2020) Vol. 29, Iss. 4, pp. 1382-1394
Open Access | Times Cited: 51
Advances in the Design of (Nano)Formulations for Delivery of Antisense Oligonucleotides and Small Interfering RNA: Focus on the Central Nervous System
Monique Culturato Padilha Mendonça, Ayse Kont, María R. Aburto, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 4, pp. 1491-1506
Open Access | Times Cited: 47
Innovative developments and emerging technologies in RNA therapeutics
François Halloy, Annabelle Biscans, Katherine E. Bujold, et al.
RNA Biology (2022) Vol. 19, Iss. 1, pp. 313-332
Open Access | Times Cited: 32
Delivery of Oligonucleotides: Efficiency with Lipid Conjugation and Clinical Outcome
Phuc Tran, Tsigereda Weldemichael, Zhichao Liu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 342-342
Open Access | Times Cited: 30
Lipid and Peptide-Oligonucleotide Conjugates for Therapeutic Purposes: From Simple Hybrids to Complex Multifunctional Assemblies
Carme Fàbrega, Anna Aviñó, Natalia Navarro, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 320-320
Open Access | Times Cited: 18
Targeting RNA with synthetic oligonucleotides: Clinical success invites new challenges
Cristina Hofman, David R. Corey
Cell chemical biology (2023) Vol. 31, Iss. 1, pp. 125-138
Open Access | Times Cited: 18
Hydrophobically Modified let-7b miRNA Enhances Biodistribution to NSCLC and Downregulates HMGA2 In Vivo
Meirav Segal, Annabelle Biscans, Maud-Emmanuelle Gilles, et al.
Molecular Therapy — Nucleic Acids (2019) Vol. 19, pp. 267-277
Open Access | Times Cited: 48
Mechanisms of palmitic acid-conjugated antisense oligonucleotide distribution in mice
Alfred E. Chappell, Hans Gaus, Andrés Berdeja, et al.
Nucleic Acids Research (2020) Vol. 48, Iss. 8, pp. 4382-4395
Open Access | Times Cited: 45
Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases
Elias Fattal, François Fay
Advanced Drug Delivery Reviews (2021) Vol. 175, pp. 113809-113809
Open Access | Times Cited: 36
Engineered ionizable lipid siRNA conjugates enhance endosomal escape but induce toxicity in vivo
Annabelle Biscans, Socheata Ly, Nicholas McHugh, et al.
Journal of Controlled Release (2022) Vol. 349, pp. 831-843
Open Access | Times Cited: 27
RNAi-based modulation of IFN-γ signaling in skin
Qi Tang, Jacquelyn Sousa, Dimas Echeverria, et al.
Molecular Therapy (2022) Vol. 30, Iss. 8, pp. 2709-2721
Open Access | Times Cited: 26
Quantifying the activity profile of ASO and siRNA conjugates in glioblastoma xenograft tumors in vivo
Samantha L. Sarli, Hassan H. Fakih, Karen Kelly, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 9, pp. 4799-4817
Open Access | Times Cited: 5
Pharmacokinetics and protein binding of cholesterol-conjugated heteroduplex oligonucleotide
Yukitake Yoshioka, S. Yamamoto, Kosuke Kusamori, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 787-799
Open Access
Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines
Mohan Liu, Yusi Wang, Yi-Bing Zhang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top